Midobrutinib
Midobrutinib (Example 13) is a BTK inhibitor (IC50: 0.813 nM) . Midobrutinib can be used for research of diseases involving BTK, particularly cancer[1].
Product Specifications
CAS Number
[1654727-33-9]
UNSPSC
12352005
Target
Btk
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(C1=NN([C@H]2CN(CCC2)C(C=C)=O)C3=NC=NC(N)=C13)NC4=NC5=CC=CC=C5O4
Molecular Formula
C21H20N8O3
Molecular Weight
432.44
References & Citations
[1]IGUCHI, Satoru, et al. Novel condensed pyrimidine compound or salt thereof. Patent. WO2015022926
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1375862-01 0.02 mg (E-Coli)
Recombinant Cuscuta sandwichiana ATP synthase subunit beta, plastid (atpB)
Ask
View Details MBS1375862-02 0.02 mg (Yeast)
Recombinant Cuscuta sandwichiana ATP synthase subunit beta, plastid (atpB)
Ask
View Details MBS1375862-03 0.1 mg (E-Coli)
Recombinant Cuscuta sandwichiana ATP synthase subunit beta, plastid (atpB)
Ask
View Details 
MBS1375862-04 0.1 mg (Yeast)
Recombinant Cuscuta sandwichiana ATP synthase subunit beta, plastid (atpB)
Ask
View Details MBS1375862-05 0.02 mg (Baculovirus)
Recombinant Cuscuta sandwichiana ATP synthase subunit beta, plastid (atpB)
Ask
View Details